EU approves production line for J&J's COVID-19 vaccine in Italy to boost supply
The Peninsula
Europe's medicines regulator said on Friday it had approved the production of Johnson & Johnson's single-dose COVID-19 vaccine at an additional site in Italy, as it looks to speed up the supply of the shot in the European Union.
The approval came after the EU said J&J was expected to miss its EU supply target for the second quarter after millions of doses were banned for use in Europe over safety concerns following a contamination incident at a U.S. site. The Italian site, located in Anagni and operated by U.S.-based Catalent, will help with vial filling and packaging of the vaccine developed by J&J, the European Medicines Agency (EMA) said.More Related News